The shape of the problem
Healthcare networks operate the toughest exposure landscape in the category. PHI on the perimeter, medical devices on flat networks, third-party clinical software with deep access, and a regulatory frame (HIPAA Security Rule, HITRUST, FDA guidance) that turns every gap into an OCR-reportable event. IBM’s 2024 Cost of a Data Breach report put average healthcare breach cost at $9.77M — the highest of any industry, and the gap above other industries widens annually.
The recurring deployment-pattern problems a CTEM rollout addresses:
- Incomplete PHI inventory — HL7 interfaces, FHIR API endpoints, automated lab feeds, and third-party integrations often operate without security oversight. Risk analyses miss systems that should be in scope.
- Medical device blind spot — connected infusion pumps, PACS imaging, patient monitors, and pharmacy management systems run embedded operating systems on network segments shared with clinical workstations. Active scanning is clinically risky.
- Vendor exposure — clinical software vendors with network or API access. Annual questionnaires miss the technical reality (exposed services, expiring certificates, unpatched edge appliances).
- Annual-cycle risk analysis — 45 CFR 164.308(a)(1) met on paper while the underlying environment changes weekly.
What the deployment pattern looks like
A healthcare CTEM deployment is structured around the safety of the clinical environment first:
PHI-handling asset taxonomy. Each asset classified at scope time by data sensitivity (PHI, PII, financial), system type (clinical application, medical device, infrastructure), and network segment. The classification propagates into prioritization — vulnerabilities on EHR systems are scored differently than the same CVE on an administrative workstation.
Passive medical-device monitoring for assets that cannot undergo active scanning. Anomalous communication patterns, unencrypted PHI transmission, unauthorized external connections — surfaced without ever sending traffic that could disrupt clinical use. Active scans run only during non-clinical maintenance windows with device-specific safety profiles.
Vendor attack-surface monitoring continuously tracks the external exposure of every vendor with PHI access. Exposed services, certificate expirations, DNS misconfigurations, and indicator-of-exploitation matches against published vulnerability catalogs — caught between annual questionnaires.
Automated HIPAA Security Rule mapping ties every finding to the relevant safeguard (164.308 administrative, 164.310 physical, 164.312 technical, 164.314 organizational). Continuous scanning produces a living risk analysis that satisfies 45 CFR 164.308(a)(1) with daily-updated data — not a static annual snapshot the auditor receives at year-end.
Clinical-aware scheduling. Patient-care impact weighs alongside technical severity. A vulnerability requiring a pharmacy-system reboot during operating hours gets different scheduling than the same vulnerability on a development server.
Operational characteristics
Three observable changes a healthcare security program sees in the first quarter on this pattern:
- PHI inventory becomes living. Previously untracked HL7 / FHIR / integration endpoints surface and enter continuous monitoring. The “we don’t know all our PHI systems” admission stops being honest because the platform actually knows.
- Medical-device program separates safe and unsafe scan paths. Active scanning happens only when safe. Passive monitoring happens always. The clinical leadership stops blocking the security program because the program respects clinical risk.
- Audit week becomes a query. OCR’s risk-analysis evidence requirement is satisfied by exporting a filtered finding set, not by re-running the annual exercise.
What this pattern does not do
CTEM does not replace clinical-engineering review of medical-device security postures, vendor contract negotiation, BAA management, or board-level governance of incident-response readiness. The platform produces the underlying evidence; those processes consume it.
This page describes a representative deployment pattern. As real customers go on the record, attributed stories with specific outcomes will appear separately — see the customer index for current state.